![Matthew Onaitis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Onaitis
Direttore Finanziario/CFO presso
MAINSTAY MEDICAL INTERNATIONAL
Profilo
Matthew W.
Onaitis is currently Director at Snp Bio, Inc. and Stratify Genomics, Inc., and Chief Financial Officer at Mainstay Medical International Ltd. since 2018.
Formerly, Mr. Onaitis was Director-Legal Affairs at Elan Corp.
Plc (2004-2005), Associate General Counsel at Biogen, Inc. (2006), Secretary, Senior Vice President & General Counsel at Somaxon Pharmaceuticals, Inc. (2010-2013), Secretary & General Counsel at Trius Therapeutics, Inc. (2013), Secretary & General Counsel at Ignyta, Inc. (2014-2016), and CFO, Secretary, CAO & General Counsel at Cidara Therapeutics, Inc. (2016-2018).
Education includes an undergraduate degree from Carnegie Mellon University (1993) and a graduate degree from Stanford Law School (1998).
Posizioni attive di Matthew Onaitis
| Società | Posizione | Inizio |
|---|---|---|
| MAINSTAY MEDICAL INTERNATIONAL | Direttore Finanziario/CFO | 20/08/2018 |
Snp Bio, Inc. | Direttore/Membro del Consiglio | - |
Stratify Genomics, Inc.
 Stratify Genomics, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer risk stratification company | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Matthew Onaitis
| Società | Posizione | Fine |
|---|---|---|
| CIDARA THERAPEUTICS | Direttore Finanziario/CFO | 17/08/2018 |
| IGNYTA INC | Consigliere Generale | 01/06/2016 |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Consigliere Generale | 01/12/2013 |
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Consigliere Generale | 01/03/2013 |
| BIOGEN INC. | Corporate Officer/Principal | 01/05/2006 |
Formazione di Matthew Onaitis
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
79
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Mainstay Medical International Ltd.
 Mainstay Medical International Ltd. Medical SpecialtiesHealth Technology Develops neurostimulation therapies for people with chronic mechanical low back pain | Health Technology |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Stanford Law School
 Stanford Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Snp Bio, Inc. | |
Stratify Genomics, Inc.
Stratify Genomics, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer risk stratification company | Health Services |
